PhaseBio Expands Executive Management Team

PhaseBio Expands Executive Management Team

MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced the expansion of its executive management team …

Read More